综述
A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Varenicline for Smoking Cessation
Hélène M. Faessel, Ronald Scott Obach, Hans Rollema, Patanjali Ravva, Kathryn E. Williams, Aaron H. Burstein
Pfizer (United States)
来源Clinical Pharmacokinetics
年份2010
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF,后续可基于全文生成更完整的速读。
逐年被引趋势
1160
1117
18
19
20
21
22
23
24
25
26
关键指标
128
被引次数 · OpenAlex
0.94
领域内被引倍数
同类平均 = 1
同类平均 = 1
前 34%
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
68
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:文献信息
论文问答
当前基于文献信息回答
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Smoking Behavior and Cessation
Pharmacogenetics and Drug Metabolism · Nicotinic Acetylcholine Receptors Study
参考文献 68
Treating Tobacco Use and Dependence: 2008 Update
被引 3,035PsycEXTRA Dataset · 2009
Antidepressants for smoking cessation
被引 687JR Hughes, LF Stead, Tim Lancaster · Cochrane Database of Systematic Reviews · 2003
Interactions of n-Tetraalkylammonium Compounds and Biguanides with a Human Renal Organic Cation Transporter (hOCT2)
被引 91Mark J. Dresser, Guangqing Xiao, Maya K. Leabman · Pharmaceutical Research · 2002
此处列出前 3 条
引用本文 128
Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis
被引 286Sonal Singh, Yoon Kong Loke, John G. Spangler · Canadian Medical Association Journal · 2011
Renal Drug Transporters and Drug Interactions
被引 233Anton Ivanyuk, Françoise Livio, Jérôme Biollaz · Clinical Pharmacokinetics · 2017
Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products
被引 145Gail D. Anderson, Lingtak‐Neander Chan · Clinical Pharmacokinetics · 2016
按被引量排序,此处列出前 3 条